Furthermore, a CRISPR/Cas9 system encoding the GFP reporter gene with a KO target of CDC6 (pSpCas9‐sgCDC6, Figure S4C, Supporting Information) was used as a therapeutic plasmid to test the cancer cell‐killing effect of gene editing. Here, CDC6 is linked to cancer.